P3 Health Partners (NASDAQ:PIII) Given New $12.50 Price Target at Lake Street Capital

P3 Health Partners (NASDAQ:PIII) had its price objective lowered by Lake Street Capital from $20.00 to $12.50 in a research report issued on Monday,Benzinga reports. The firm presently has a “buy” rating on the stock. Lake Street Capital’s price target would indicate a potential upside of 100.00% from the stock’s previous close.

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of P3 Health Partners in a research note on Wednesday, October 8th. One equities research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $12.50.

P3 Health Partners Price Performance

NASDAQ PIII traded down $0.59 on Monday, reaching $6.25. 7,153 shares of the company’s stock traded hands, compared to its average volume of 19,720. P3 Health Partners has a 12 month low of $5.80 and a 12 month high of $14.50. The company has a debt-to-equity ratio of 2.29, a current ratio of 0.31 and a quick ratio of 0.31. The stock has a 50-day simple moving average of $8.63 and a 200 day simple moving average of $7.67. The stock has a market cap of $44.92 million, a PE ratio of -0.16 and a beta of 0.84.

P3 Health Partners (NASDAQ:PIII) last announced its quarterly earnings data on Friday, November 14th. The company reported ($9.67) earnings per share for the quarter, missing analysts’ consensus estimates of ($8.70) by ($0.97). P3 Health Partners had a negative return on equity of 203.68% and a negative net margin of 9.07%.The business had revenue of $345.25 million during the quarter, compared to the consensus estimate of $346.64 million. P3 Health Partners has set its FY 2025 guidance at EPS. As a group, research analysts predict that P3 Health Partners will post -0.67 earnings per share for the current year.

Hedge Funds Weigh In On P3 Health Partners

A hedge fund recently raised its stake in P3 Health Partners stock. Trinity Financial Advisors LLC grew its position in shares of P3 Health Partners Inc. (NASDAQ:PIII) by 22.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,278,037 shares of the company’s stock after acquiring an additional 234,500 shares during the period. Trinity Financial Advisors LLC owned about 17.80% of P3 Health Partners worth $222,000 as of its most recent SEC filing. 7.75% of the stock is currently owned by hedge funds and other institutional investors.

P3 Health Partners Company Profile

P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc was founded in 2020 and is based in Henderson, Nevada.